Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
about
Has the DOTS strategy improved case finding or treatment success? An empirical assessmentA three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in childrenHigh rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test resultsHuman CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokinesRecent developments in treatment of latent tuberculosis infectionThe Role of Laboratory Tests in Crohn's DiseaseDiagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This stCompletion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinicUse of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposureTuberculosis among health-care workers in low- and middle-income countries: a systematic review.Using ELISPOT to expose false positive skin test conversion in tuberculosis contactsThe presence of a booster phenomenon among contacts of active pulmonary tuberculosis cases: a retrospective cohortHeparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data.Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection.Biomarker changes associated with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts.Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic reviewReferrals for positive tuberculin tests in new health care workers and students: a retrospective cohort study.Contact investigation after a fatal case of extensively drug-resistant tuberculosis (XDR-TB) in an aircraft, Germany, July 2013Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.Decreasing household contribution to TB transmission with age: a retrospective geographic analysis of young people in a South African townshipTuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigensDiscordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.Tuberculosis: 10. PreventionAdded value of QuantiFERON TB-gold in-tube for detecting latent tuberculosis infection among persons living with HIV/AIDS.Saudi guidelines for testing and treatment of latent tuberculosis infectionReproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivityImportance of cough and M. tuberculosis strain type as risks for increased transmission within households.Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda.Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda.Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study.Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review.Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections.High annual risk of tuberculosis infection among nursing students in South India: a cohort study.Results of five-year systematic screening for latent tuberculosis infection in healthcare workers in PortugalHigh prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.
P2860
Q21144342-FDD31A36-F51D-4A31-9C98-DC11E1971C84Q21562599-E6D99585-97F8-4A6C-8BBC-61D1BF6B91F7Q23917093-873FD525-F417-4B0B-A90E-2883D3EBC44EQ24316479-33E5AF24-2FFB-485C-982B-55A864EDA442Q24630473-95AA7022-EBDA-4686-BAAC-8481C48509A5Q28075045-2735C0A8-58BC-4CE5-B63A-AC45F4392B2FQ28376762-70DCCA32-65DF-40F9-8C97-6954B348D5E0Q28484855-F6094F47-A93F-4F41-AE3E-DE4CD76A2615Q30863509-4E6E25A0-5842-46E5-856E-D49358D0E628Q33267833-D0468468-C43A-4B9F-A938-FFC2A71FE134Q33271020-1E323CB7-CE38-4C81-ACC0-947C04EF6AA9Q33279360-BAC35AE9-6B39-42A8-8AB0-2C6FB9B1A8B7Q33301317-FE78970C-A540-46F2-B9D9-3A21E5929ACDQ33325475-8896BC72-85FC-4F2D-B7DE-9D434FC1B066Q33444815-1AB096AF-6614-48FB-B90A-53A28E6884C5Q33510346-37D78B4D-6A95-40E1-9002-B2AE4956B762Q33521202-5C38F433-A2E9-41C4-99EB-66E40937C75DQ33525377-9FAF2421-83AC-4B90-A100-56949481BEE0Q33553272-E618268C-F7E3-4FE3-94B8-D1B63E466AA1Q33567995-D5C10149-A09F-4DA3-9833-335508B40F59Q33574194-1B20CD6E-828B-49A7-AF78-E503CBA0003FQ33591688-771899EC-EAAC-4096-8F4D-0EEE1B163245Q33593498-6AD98EA0-426B-4E25-90C8-3FE391485A29Q33599396-1F2B22E3-B2B4-469E-9D8B-4AD2A26CDB86Q33638976-17FE7C88-05A8-4A0C-8F78-13387510B6CDQ33747666-1800AB20-CFDF-41C4-B526-1C736BCA4FB8Q33759993-119B6C5B-9FFE-473D-81F7-1741E2D96423Q33772114-5AAFC0A0-EDA8-450D-98FB-D683A690A2DBQ33792760-137540B6-DA01-4103-BD13-7048FB1C7046Q33807446-D0AED6DE-8859-4F41-8D00-1E5D6ECDC73EQ33838401-FFE6EAF8-230F-4603-81C4-6A390E0B9878Q33847573-B6FF960F-5FCF-4125-8FED-218D1723FE22Q33880649-2138CBB1-E430-4181-B35B-3FB31F22A14EQ33919181-3E5D9A50-757A-4205-A826-FD50565DF069Q33939033-7F0978C9-5D72-4E36-881E-8E89C6B43754Q33998970-40106CFB-819A-4081-8A48-D803A5488D3BQ34024833-67DBAB7A-B709-4276-A9C7-6C9E4E74DB5EQ34056148-03CD8C80-E9FB-43C4-9652-CB3DDFF1C650Q34064827-ECC41B8E-35EA-4BF7-87F7-EBD7484DD473Q34075496-90D49000-1426-4EEF-A538-56ACF95B6C76
P2860
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@ast
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@en
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@nl
type
label
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@ast
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@en
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@nl
prefLabel
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@ast
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@en
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@nl
P2860
P1476
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
@en
P2093
P2860
P356
10.1164/AJRCCM.159.1.9801120
P407
P577
1999-01-01T00:00:00Z